Monte Rosa Therapeutics, Inc. (GLUE): SCHEDULE 13D/A filed Jan 9, 2026

Form type

SCHEDULE 13D/A

Filing date

Jan 9, 2026

Accession number

0001193125-26-008951

Filer

Monte Rosa Therapeutics, Inc. (CIK 1826457)